SCHEMBL13309119

SCHEMBL13309119

Bc1cnn2c(Nc3ccc(S(=O)(=O)O)cc3)cc(-c3ccccc3F)nc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 7/20 0.58
▸ CDK2 P24941 7/20 0.42
▸ CCNA2 P20248 1/20 0.42
▸ CCNA1 P78396 1/20 0.42
▸ KDM4E B2RXH2 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ CLK1 P49759 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ SNCA P37840 1/20 0.36
▸ TP53 P04637 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ ADORA3 P0DMS8 2/20 0.34
▸ ADORA2A P29274 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13308740 0.88 GSK3B (0.76) GSK3BCDK2CCNA2CCNA1KDM4E
SCHEMBL13309082 0.86 GSK3B (0.46) GSK3BCDK2KDM4EALDH1A1LMNA
SCHEMBL13885032 0.78 GSK3B (0.79) GSK3BCDK2CCNA2CCNA1
SCHEMBL13885030 0.78 GSK3B (0.70) GSK3BCDK2CCNA2CCNA1
SCHEMBL14050973 0.76 GSK3B (0.62) GSK3BCDK2CCNA2CCNA1LMNA
SCHEMBL13309399 0.76 MAPK1 (0.45) GSK3BCDK2KDM4EALDH1A1LMNA
SCHEMBL13893805 0.76 GSK3B (0.48) GSK3BCDK2KDM4EALDH1A1LMNA
SCHEMBL13309467 0.75 GSK3B (0.67) GSK3BCDK2CCNA2CCNA1
SCHEMBL12953482 0.74 GSK3B (0.77) GSK3BCDK2CCNA2CCNA1
SCHEMBL13309050 0.74 ALDH1A1 (0.47) GSK3BKDM4EALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1934224-B1 PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS FOR THE TREATMENT OF CANCER SCHERING CORP (US) 2010-06-09 — — EP disclosed
Send feedback